Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

27.16
+2.098.34%
Post-market: 27.160.00000.00%19:30 EDT
Volume:141.23K
Turnover:3.65M
Market Cap:286.57M
PE:-8.68
High:27.40
Open:25.21
Low:24.07
Close:25.07
52wk High:31.31
52wk Low:5.26
Shares:10.55M
Float Shares:4.98M
Volume Ratio:1.15
T/O Rate:2.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1298
EPS(LYR):-4.6702
ROE:-540.01%
ROA:-14.05%
PB:31.34
PE(LYR):-5.82

Loading ...

Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 01, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 27, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report
Dec 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 10, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 09, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 26, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 23, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 23, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 23, 2020

Correspondence

CORRESP [Cover] - Correspondence